quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:00:52·106d
SECFiling
Propanc Biopharma Inc. logo

Propanc Biopharma Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

PPCB· Propanc Biopharma Inc.
Health Care
Original source

Companies

  • PPCB
    Propanc Biopharma Inc.
    Health Care

Related

  • SEC3d
    SEC Form EFFECT filed by Propanc Biopharma Inc.
  • SEC13d
    SEC Form S-1 filed by Propanc Biopharma Inc.
  • SEC24d
    SEC Form DEF 14C filed by Propanc Biopharma Inc.
  • PR31d
    Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain
  • SEC35d
    SEC Form PRE 14C filed by Propanc Biopharma Inc.
  • SEC35d
    SEC Form PRE 14A filed by Propanc Biopharma Inc.
  • PR43d
    Propanc Biopharma Targets $3B+ Pancreatic Cancer Market with PRP: 85%+ Tumor Inhibition in Breakthrough Proenzyme Therapy
  • PR45d
    Propanc Biopharma Executes Service Agreement with FyoniBio to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022